Results 151 to 160 of about 385,811 (204)

Innovative webinar-based training to support evidence-to-recommendation decision-making by national immunization technical advisory groups: multi-country experience with hexavalent vaccines.

Vaccine
Torre L, Hadler SC, Hopkins KL, Sommers T, Best T, Ndiaye S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Inactivated poliovirus vaccine: past and present experience

Vaccine, 1996
Many countries have made use of inactivated poliovirus vaccine (IPV) in their national poliovirus control programs since 1955. Until 1961 IPV was the only vaccine available for the control of poliovirus, but subsequently many countries opted to use the Sabin attenuated poliovirus vaccine (OPV), which was perceived as more effective in preventing ...
Luis Barreto
exaly   +3 more sources

World wide experience with inactivated poliovirus vaccine

Vaccine, 2008
As part of the global poliovirus eradication strategy, oral poliovirus vaccine (OPV) has successfully contributed to reduce polio incidence rates globally. However, because of the OPV-related risks of vaccine associated paralytic poliomyelitis (VAPP) and vaccine-derived polioviruses (VDPVs) OPV cessation is required in order to achieve complete ...
Marie-Claude, Bonnet, Anil, Dutta
exaly   +3 more sources

Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation

Journal of Infectious Diseases, 2014
Background: The Global Polio Eradication Initiative plans to stop all oral poliovirus vaccine (OPV) after wild poliovirus eradication, starting with serotype 2.
Kimberly M Thompson, Radboud Duintjer Tebbens, Duintjer Tebbens Radboud J   +2 more
exaly   +3 more sources

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies [PDF]

Trials in Vaccinology, 2015
IntroductionWe conducted a follow-on study to a phase I randomized, controlled trial conducted in Cuba, 2012, to assess the persistence of poliovirus antibodies at 21–22months following booster dose of Sabin-IPV compared to Salk-IPV in adults who had ...
Sonia Resik, Roland W Sutter, Hiromasa Okayasu   +2 more
exaly   +2 more sources

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame [PDF]

Expert Review of Vaccines, 2015
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve this aim, it is essential to block viral replication in individuals via induction of a robust mucosal immune response. Although it has long been recognized
Margarita Pons-Salort, Nicholas Grassly, Kathleen O'Reilly   +2 more
exaly   +2 more sources

Intestinal immunity induced by inactivated poliovirus vaccine

Vaccine, 1987
In order to detect any intestinal immunity against poliovirus infection induced by parenteral vaccination with inactivated poliovirus vaccine (IPV), experiments were conducted in monkeys (Macaca radiata).
T J John
exaly   +2 more sources

Vaccination with Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine in Denmark

Clinical Infectious Diseases, 1984
In Denmark a polio vaccination program including both inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine ( OPV ) has been in use since 1968. Three injections of IPV are given when the children are five, six, and 15 months of age. Subsequently, three vaccinations with trivalent OPV are administered at the age of three, four, and five years.
H, von Magnus, I, Petersen
openaire   +2 more sources

Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine

Vaccine, 1998
Seventy eight infants aged 6-8 weeks received either two doses of 0.1 ml of inactivated poliovirus vaccine (IPV) intradermally 8 weeks apart (group A) or three doses 4 weeks apart (group B).
T J John, Thomas Cherian
exaly   +2 more sources

Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands

Clinical Diagnostic Laboratory Immunology, 1997
In The Netherlands the inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis. It is not clear if parenteral vaccination with IPV can lead to priming of the mucosal immune system. We developed and evaluated enzyme-linked immunosorbent assays for the detection of poliovirus serotype-specific immunoglobulin A (IgA) and ...
Herremans, MMPT, van Loon, AM, Reimerink, JHJ, Rumke, HC, van der Avoort, HGAM, Kimman, TG, Koopmans, MPG   +6 more
openaire   +4 more sources